We are live on
!
Find out more
BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$159M
1-Year Est. Return
139.66%
This Fund
S&P 500
This Quarter
Est. Return
+45.04%
1 Year Est. Return
+139.66%
3 Year Est. Return
+503.09%
5 Year Est. Return
+228.74%
10 Year Est. Return
–
AUM
$170M
AUM Growth
–
Cap. Flow
+$144M
Cap. Flow
% of AUM
84.34%
Top 10 Holdings %
Top 10 Hldgs %
92.94%
Holding
21
New
21
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CareDx
CDNA
|
+$24.8M |
| 2 |
Natera
NTRA
|
+$23.8M |
| 3 |
CELL
PhenomeX Inc. Common Stock
CELL
|
+$16.6M |
| 4 |
Guardant Health
GH
|
+$16.2M |
| 5 |
Adaptive Biotechnologies
ADPT
|
+$10.7M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 89.82% |
| 2 | Materials | 7.58% |
| 3 | Technology | 1.27% |
| 4 | Consumer Discretionary | 0.38% |
| 5 | Communication Services | 0.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
CareDx
CDNA
$2.41B
| $31M | 18.18% |
+427,500
| New | +$24.8M |
|
|
2
Natera
NTRA
$46.9B
| $28.3M | 16.64% |
+284,801
| New | +$23.8M |
|
|
3
Guardant Health
GH
$21.9B
| $18.2M | 10.66% |
+140,900
| New | +$16.2M |
|
|
CELL
4
DELISTED
PhenomeX Inc. Common Stock
CELL
| $17.7M | 10.36% |
+197,477
| New | +$16.6M |
|
|
AMRS
5
DELISTED
Amyris Inc.
AMRS
| $12.9M | 7.58% |
+2,092,216
| New | +$6.69M |
|
|
6
Adaptive Biotechnologies
ADPT
$4.07B
| $12.3M | 7.22% |
+208,100
| New | +$10.7M |
|
7
Illumina
ILMN
$31B
| $10.9M | 6.38% |
+30,223
| New | +$9.63M |
|
8
Twist Bioscience
TWST
$8.93B
| $10.3M | 6.07% |
+73,178
| New | +$8.12M |
|
|
EXAS
9
DELISTED
Exact Sciences
EXAS
| $9.97M | 5.85% |
+75,250
| New | +$9.1M |
|
|
GNMK
10
DELISTED
GenMark Diagnostics, Inc
GNMK
| $6.81M | 4% |
+466,337
| New | +$6.18M |
|
11
Thermo Fisher Scientific
TMO
$227B
| $6.8M | 3.99% |
+14,600
| New | +$6.85M |
|
12
Sprott Physical Gold
PHYS
$16.2B
| $688K | 0.4% |
+45,626
| New | +$678K |
|
13
Amazon
AMZN
$2.87T
| $651K | 0.38% |
+4,000
| New | +$638K |
|
14
Microsoft
MSFT
$3.6T
| $606K | 0.36% |
+2,726
| New | +$586K |
|
15
Adobe
ADBE
$108B
| $547K | 0.32% |
+1,094
| New | +$529K |
|
16
Alphabet (Google) Class A
GOOGL
$4.22T
| $535K | 0.31% |
+6,100
| New | +$513K |
|
17
Apple
AAPL
$4.62T
| $531K | 0.31% |
+4,000
| New | +$481K |
|
18
NVIDIA
NVDA
$5.27T
| $474K | 0.28% |
+36,280
| New | +$486K |
|
19
Stryker
SYK
$130B
| $441K | 0.26% |
+1,800
| New | +$408K |
|
20
Visa
V
$682B
| $396K | 0.23% |
+1,809
| New | +$370K |
|
21
Intuitive Surgical
ISRG
$141B
| $360K | 0.21% |
+1,320
| New | +$328K |
|
Similar funds
SFC
ACP
CW
SG
LA
CMMS
JWM
AC
Blue Water Life Science Advisors's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Blue Water Life Science Advisors, which disclosed 21 positions worth $170M. Its ten largest holdings account for 93% of the portfolio.
Its largest position is CareDx: 427,500 shares worth $31M.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, followed by Materials and Technology.
- Blue Water Life Science Advisors's largest Q4 2020 buy was CareDx: 427,500 shares worth $31M.
- Blue Water Life Science Advisors's ten largest holdings make up 93% of its $170M portfolio in Q4 2020.
- Blue Water Life Science Advisors disclosed 21 positions in Q4 2020, its first 13F filing on record.
Based on Blue Water Life Science Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.